Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Replication deficient recombinant adenovirus vector

Replication deficient recombinant adenovirus vector

US Patent 6136594 · Granted Oct 24, 2000

Estimated economic value: $968,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mesenchymal stem cell-derived exosomes and their uses2024
Lymphocyte biomarkers for determining the clinical response to cell therapy2022
Biomarkers for determining the clinical response to cell therapy2020
Lymphocyte biomarkers for determining the clinical response to cell therapy2020
Adenovirus vaccine vectors2018
Recombinant adenoviruses encoding the specific iodine transporter (NIS)2014
Defective recombinant adenoviruses expressing cytokines for antitumor treatment2007
Defective adenoviruses and corresponding complementation lines2006
Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell lin2006
Recombinant adenoviruses for gene therapy in cancers2006
Defective adenoviruses and corresponding complementation lines2006
Targeted adenovirus vectors for delivery of heterologous genes2005